Clindamycin, metronidazole, and chloramphenicol

被引:85
作者
Kasten, MJ [1 ]
机构
[1] Mayo Clin, Div Infect Dis & Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA
关键词
D O I
10.4065/74.8.825
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clindamycin, metronidazole, and chloramphenicol are three antimicrobial agents useful in the treatment of anaerobic infections. Clindamycin is effective in the treatment of most infections involving anaerobes and grampositive cocci, but emerging resistance has become a problem in some clinical settings. Metronidazole is effective in the treatment of infections involving gram-negative anaerobes, but it is unreliable in the treatment of gram-positive anaerobic infections and is ineffective in treating aerobic infections. Additionally, metronidazole is often the drug of choice in treating infections in which Bacteroides fragilis is a serious concern. Chloramphenicol is effective in the treatment of a wide variety of bacterial infections, including serious anaerobic infections, but is rarely used in Western countries because of concerns about toxicity, including aplastic anemia and gray baby syndrome.
引用
收藏
页码:825 / 833
页数:9
相关论文
共 107 条